Drug Side Effects
Search
BLADDER CANCER STAGE III
BLADDER CANCER STAGE III
was reported 1210 times
BLADDER CANCER STAGE III is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
GLP-2 Analog [EPC]
1
0.0001
1
Sulfonylurea [EPC]
4
0.0000
2
beta3-Adrenergic Agonist [EPC]
1
0.0000
3
Erythropoiesis-stimulating Agent [EPC]
1
0.0000
4
Peroxisome Proliferator Receptor alpha Agonist [EPC]
1
0.0000
5
Interferon beta [EPC]
3
0.0000
6
Insulin Analog [EPC]
5
0.0000
7
Angiotensin 2 Receptor Blocker [EPC]
3
0.0000
8
Parathyroid Hormone Analog [EPC]
1
0.0000
9
Fluoroquinolone Antibacterial [EPC]
1
0.0000
10
Platinum-based Drug [EPC]
2
0.0000
11
Nucleoside Metabolic Inhibitor [EPC]
2
0.0000
12
alpha-Adrenergic Blocker [EPC]
1
0.0000
13
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
0.0000
14
HMG-CoA Reductase Inhibitor [EPC]
2
0.0000
15
Factor Xa Inhibitor [EPC]
1
0.0000
16
Platelet Aggregation Inhibitor [EPC]
2
0.0000
17
beta-Adrenergic Blocker [EPC]
1
0.0000
18
Benzodiazepine [EPC]
2
0.0000
19
Vitamin C [EPC]
1
0.0000
20
Nonsteroidal Anti-inflammatory Drug [EPC]
3
0.0000
21
GLP-1 Receptor Agonist [EPC]
1
0.0000
22
Loop Diuretic [EPC]
1
0.0000
23
Tumor Necrosis Factor Blocker [EPC]
2
0.0000
24
Interleukin-4 Receptor alpha Antagonist [EPC]
1
0.0000
25
Thalidomide Analog [EPC]
1
0.0000
26
Corticosteroid [EPC]
1
0.0000